NovoCare
Novo Nordisk's direct-pay self-pay program for Wegovy and other branded GLP-1s.
The Novo Nordisk equivalent of LillyDirect: a self-pay channel offering Wegovy from about $499/mo for eligible cash-pay patients, plus savings-card support for the insured.